
From today Monday alcohol dependant patients in Finland, Norway, Poland and the Baltic countries will have access to Lundbecks new pill against alcohol addiction, Selincro, the Danish company informs in a press release.
“We are proud to make Selincro available to patients suffering from alcohol dependence. This is an area with significant unmet medical needs, and we are excited about introducing an innovative treatment concept that provides a new and different option for patients who may otherwise not seek treatment”, says Ole Chrintz, Senior Vice President, International Markets and Europe at Lundbeck.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app